Article Details

AstraZeneca boosts cancer portfolio with $320 mln Neogene deal | Reuters

Retrieved on: 2022-11-29 08:56:48

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca boosts cancer portfolio with $320 mln Neogene deal | Reuters. View article details on hiswai:

Excerpt

AstraZeneca will acquire biotechnology company Neogene Therapeutics for up to $320 million, the London-listed drugmaker said on Tuesday, ...

Article found on: www.reuters.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up